NewGenIvf Group (NIVF) Competitors $0.56 -0.03 (-5.68%) (As of 12:04 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends NIVF vs. OTRK, ATIP, MGRX, KDLY, ATPC, BGLC, VSEE, CMAX, ACON, and BACKShould you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Ontrak (OTRK), ATI Physical Therapy (ATIP), Mangoceuticals (MGRX), Kindly MD (KDLY), Agape ATP (ATPC), BioNexus Gene Lab (BGLC), Vsee Health (VSEE), CareMax (CMAX), Aclarion (ACON), and IMAC (BACK). These companies are all part of the "healthcare" industry. NewGenIvf Group vs. Ontrak ATI Physical Therapy Mangoceuticals Kindly MD Agape ATP BioNexus Gene Lab Vsee Health CareMax Aclarion IMAC NewGenIvf Group (NASDAQ:NIVF) and Ontrak (NASDAQ:OTRK) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, community ranking, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation. Which has more volatility & risk, NIVF or OTRK? NewGenIvf Group has a beta of 0.2, indicating that its stock price is 80% less volatile than the S&P 500. Comparatively, Ontrak has a beta of 2.59, indicating that its stock price is 159% more volatile than the S&P 500. Does the media prefer NIVF or OTRK? In the previous week, NewGenIvf Group had 4 more articles in the media than Ontrak. MarketBeat recorded 5 mentions for NewGenIvf Group and 1 mentions for Ontrak. NewGenIvf Group's average media sentiment score of 0.15 beat Ontrak's score of -0.58 indicating that NewGenIvf Group is being referred to more favorably in the media. Company Overall Sentiment NewGenIvf Group Neutral Ontrak Negative Is NIVF or OTRK more profitable? NewGenIvf Group has a net margin of 0.00% compared to Ontrak's net margin of -237.77%. NewGenIvf Group's return on equity of 0.00% beat Ontrak's return on equity.Company Net Margins Return on Equity Return on Assets NewGenIvf GroupN/A N/A N/A Ontrak -237.77%-171.34%-113.42% Which has better earnings & valuation, NIVF or OTRK? NewGenIvf Group has higher earnings, but lower revenue than Ontrak. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNewGenIvf Group$5.14M0.41$130KN/AN/AOntrak$12.74M0.61-$27.92M-$10.62-0.17 Do analysts rate NIVF or OTRK? Ontrak has a consensus price target of $45.00, suggesting a potential upside of 2,352.32%. Given Ontrak's stronger consensus rating and higher possible upside, analysts clearly believe Ontrak is more favorable than NewGenIvf Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NewGenIvf Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Ontrak 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor NIVF or OTRK? Ontrak received 38 more outperform votes than NewGenIvf Group when rated by MarketBeat users. CompanyUnderperformOutperformNewGenIvf GroupN/AN/AOntrakOutperform Votes3859.38% Underperform Votes2640.63% Do institutionals and insiders hold more shares of NIVF or OTRK? 66.2% of NewGenIvf Group shares are held by institutional investors. Comparatively, 13.0% of Ontrak shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by insiders. Comparatively, 1.9% of Ontrak shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryNewGenIvf Group beats Ontrak on 8 of the 15 factors compared between the two stocks. Ad Wide Moat ResearchTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. Get NewGenIvf Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIVF vs. The Competition Export to ExcelMetricNewGenIvf Grouphealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.09M$2.16B$5.09B$8.79BDividend YieldN/A7.23%5.04%4.07%P/E RatioN/A11.4193.0914.02Price / Sales0.416.101,220.6787.41Price / Cash15.1410.1339.4936.27Price / Book5.103.856.936.33Net Income$130,000.00$69.56M$118.83M$225.71M7 Day Performance-9.70%-2.24%-1.74%-0.58%1 Month Performance-50.77%0.67%-3.60%1.49%1 Year PerformanceN/A-19.41%31.91%27.23% NewGenIvf Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIVFNewGenIvf Group1.6259 of 5 stars$0.56-5.7%N/AN/A$2.09M$5.14M0.00N/AGap DownOTRKOntrak2.7325 of 5 stars$1.84+0.3%$45.00+2,352.3%-79.4%$7.74M$12.74M0.00250Gap DownATIPATI Physical Therapy0.224 of 5 stars$1.51-5.3%N/A-78.2%$6.64M$699.02M0.005,600MGRXMangoceuticals0.508 of 5 stars$2.53+2.4%N/A-98.1%$6.30M$730,000.000.003Gap DownKDLYKindly MD0.1582 of 5 stars$1.00+9.5%N/AN/A$5.96MN/A0.00N/AGap UpATPCAgape ATP0.013 of 5 stars$1.47+2.1%N/A-92.4%$5.87M$1.43M0.0040BGLCBioNexus Gene LabN/A$0.29-3.3%N/A-22.6%$5.21M$9.77M0.0030VSEEVsee Health0.3541 of 5 stars$1.31-0.8%N/AN/A$4.72MN/A0.00N/ANews CoverageGap UpCMAXCareMax1.0108 of 5 stars$0.83+12.2%N/A-97.4%$3.17M$751.10M0.001,450ACONAclarion2.6062 of 5 stars$0.18-0.2%$1.50+752.3%-95.9%$1.84M$80,000.000.007News CoveragePositive NewsBACKIMACN/A$1.02-1.0%N/A-29.9%$1.17M$16.19M0.00180 Related Companies and Tools Related Companies Ontrak Alternatives ATI Physical Therapy Alternatives Mangoceuticals Alternatives Kindly MD Alternatives Agape ATP Alternatives BioNexus Gene Lab Alternatives Vsee Health Alternatives CareMax Alternatives Aclarion Alternatives IMAC Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NIVF) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewGenIvf Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NewGenIvf Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.